Alpha 2.0
Login Register
» Authors » Sonya Pritchard

Sonya Pritchard

Explore the profile of Sonya Pritchard including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 217
Followers 0
Related Specialties
Oncology
Allergy & Immunology
Top 10 Co-Authors
Bruce Ruggeri
Robert Hudkins
Mark Ator
Hong Chang
Kathryn Hunter
Susan Jones-Bolin
Pawel Dobrzanski
Hugh Zhao
Candy Robinson
Craig Dionne
Published In
Mol Cancer Ther
Cancer Res
Hum Vaccin Immunother
Affiliations
Soon will be listed here.
Recent Articles
1.
Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
Seid C, Curti E, Mark Jones R, Hudspeth E, Rezende W, Pollet J, et al.
Hum Vaccin Immunother . 2015 Apr; 11(6):1474-88. PMID: 25905574
Over 400 million people living in the world's poorest developing nations are infected with hookworms, mostly of the genus Necator americanus. A bivalent human hookworm vaccine composed of the Necator...
2.
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity
Miknyoczki S, Chang H, Grobelny J, Pritchard S, Worrell C, McGann N, et al.
Mol Cancer Ther . 2007 Aug; 6(8):2290-302. PMID: 17699724
The effect of the potent and selective poly(ADP-ribose) (PAR) polymerase-1 [and PAR polymerase-2] inhibitor CEP-8983 on the ability to sensitize chemoresistant glioblastoma (RG2), rhabdomyosarcoma (RH18), neuroblastoma (NB1691), and colon carcinoma...
3.
Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist
Dobrzanski P, Hunter K, Jones-Bolin S, Chang H, Robinson C, Pritchard S, et al.
Cancer Res . 2004 Feb; 64(3):910-9. PMID: 14871820
Tumor-associated angiogenesis is critical for tumor growth and metastasis and is controlled by various pro- and antiangiogenic factors. The Eph family of receptor tyrosine kinases has emerged as one of...
4.
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models
Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, et al.
Cancer Res . 2003 Oct; 63(18):5978-91. PMID: 14522925
Inhibition of the vascular endothelial growth factor VEGF-VEGF receptor (VEGF-R) kinase axes in the tumor angiogenic cascade is a promising therapeutic strategy in oncology. CEP-7055 is the fully synthetic orally...
5.
Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor
Miknyoczki S, Jones-Bolin S, Pritchard S, Hunter K, Zhao H, Wan W, et al.
Mol Cancer Ther . 2003 Apr; 2(4):371-82. PMID: 12700281
Poly(ADP-ribose) polymerase 1 (PARP-1) is a nuclear zinc finger DNA-binding protein that is implicated in the repair of DNA damage. Inhibition of PARP-1 through genetic knockouts causes cells to become...